Cargando…

Novel Methods of Incorporating Time in Longitudinal Multivariate Analysis Reveals Hidden Associations With Disease Activity in Systemic Lupus Erythematosus

Objective: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease. SLE is characterized by high inter-patient variability, including fluctuations over time, a factor which most biomarker studies omit from consideration. We investigated relationships between disease activity and bioma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nim, Hieu T., Connelly, Kathryn, Vincent, Fabien B., Petitjean, François, Hoi, Alberta, Koelmeyer, Rachel, Boyd, Sarah E., Morand, Eric F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653068/ https://www.ncbi.nlm.nih.gov/pubmed/31379847 http://dx.doi.org/10.3389/fimmu.2019.01649

Ejemplares similares

Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis
por: Northcott, Melissa, et al.
Publicado: (2022)

High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus
por: Koelmeyer, Rachel, et al.
Publicado: (2020)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2020)

Analysis of serum B cell‐activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2019)

Immunosuppressant exposure confounds gene expression analysis in systemic lupus erythematosus
por: Northcott, Melissa, et al.
Publicado: (2022)

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus
por: Mende, Rachel, et al.
Publicado: (2018)

Clinical associations of serum interleukin-17 in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2013)

Disease course following High Disease Activity Status revealed patterns in SLE
por: Hoi, Alberta, et al.
Publicado: (2021)

The performance of different classification criteria for systemic lupus erythematosus in a real-world rheumatology department
por: Tan, Brandon C H, et al.
Publicado: (2022)

Cardiovascular risk profiles in a lupus cohort: what do different calculators tell us?
por: Boulos, Daniel, et al.
Publicado: (2017)

Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus
por: Vincent, Fabien B, et al.
Publicado: (2018)

Characteristics of azathioprine use and cessation in a longitudinal lupus cohort
por: Croyle, Lucy, et al.
Publicado: (2015)

Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus
por: Connelly, K. L., et al.
Publicado: (2018)

Clinical associations of cognitive dysfunction in systemic lupus erythematosus
por: Raghunath, Sudha, et al.
Publicado: (2023)

Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus
por: Godsell, Jack, et al.
Publicado: (2016)

Association of clinic setting with quality indicator performance in systemic lupus erythematosus: a cross-sectional study
por: Sreedharan, Sidha, et al.
Publicado: (2022)

Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus
por: Connelly, K. L., et al.
Publicado: (2016)

Fibromyalgia, mood disorders, cognitive test results, cognitive symptoms and quality of life in systemic lupus erythematosus
por: Raghunath, Sudha, et al.
Publicado: (2022)

A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus
por: Oon, Shereen, et al.
Publicado: (2019)

External Validation of the Lupus Multivariable Outcome Score for Systemic Lupus Erythematosus Trials
por: Abrahamowicz, Michal, et al.
Publicado: (2022)

Associations of metabolic syndrome in SLE
por: Apostolopoulos, Diane, et al.
Publicado: (2020)

Independent associations of lymphopenia and neutropenia in patients with systemic lupus erythematosus: a longitudinal, multinational study
por: Kandane-Rathnayake, Rangi, et al.
Publicado: (2021)

Machine learning applied to whole‐blood RNA‐sequencing data uncovers distinct subsets of patients with systemic lupus erythematosus
por: Figgett, William A, et al.
Publicado: (2019)

Editorial: Focus on Systemic Lupus Erythematosus
por: Harris, James, et al.
Publicado: (2016)

Granulocyte colony‐stimulating factor is not pathogenic in lupus nephritis
por: Gottschalk, Timothy A., et al.
Publicado: (2021)

Hidden in Plain Sight: Esophageal Dysmotility in Patients With Systemic Lupus Erythematosus
por: Turshudzhyan, Alla, et al.
Publicado: (2022)

Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort
por: Yap, K S, et al.
Publicado: (2015)

MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus
por: Lang, Tali, et al.
Publicado: (2015)

Cancer risk factors in systemic lupus erythematosus: multivariate regression analysis in 16,409 patients
por: Bernatsky, Sasha, et al.
Publicado: (2014)

Treatment of systemic lupus erythematosus
por: McKeon, Kathryn P, et al.
Publicado: (2020)

Systemic Lupus Erythematosus Management in Pregnancy
por: Dao, Kathryn H, et al.
Publicado: (2022)

Lupus Erythematosus
por: Gardiner, Frederick
Publicado: (1923)

Lupus Erythematosus
por: Ravogli, A.
Publicado: (1887)

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
por: Mao, Qiu-Xia, et al.
Publicado: (2017)

Causal effects of systemic lupus erythematosus on endometrial cancer: A univariable and multivariable Mendelian randomization study
por: Wan, An, et al.
Publicado: (2022)

Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus
por: Morand, Eric F, et al.
Publicado: (2023)

Relationship of anifrolumab pharmacokinetics with efficacy and safety in patients with systemic lupus erythematosus
por: Chia, Yen Lin, et al.
Publicado: (2021)

Acute longitudinal myelitis as the first presentation in child with systemic lupus erythematosus
por: Shivamurthy, Vinay M., et al.
Publicado: (2013)

Comparison of performance of specific (SLEQOL) and generic (SF36) health-related quality of life questionnaires and their associations with disease status of systemic lupus erythematosus: a longitudinal study
por: Louthrenoo, Worawit, et al.
Publicado: (2020)

Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abatacept
por: Tarazi, Meera, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l94ckr7m8eerde2b4lc2fapb86